🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12475+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12475 recruiting trials

Phase 2RecruitingNCT05583721

Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PET

👨‍⚕️ Parul Rai, MD, St. Jude Children's Research Hospital📍 1 site📅 Started Oct 2023View details ↗
Phase 3RecruitingNCT06092957

Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy

👨‍⚕️ Ming-Yuan Chen, MD,PhD, Sun Yat-sen University📍 1 site📅 Started Oct 2023View details ↗
EARLY_Phase 1RecruitingNCT06107400

Safety and Efficacy of RM-004 Cells for Hemoglobin H-Constant Spring Disease

👨‍⚕️ Xinhua Zhang, MD, The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army📍 1 site📅 Started Oct 2023View details ↗
NARecruitingNCT06047405

NIV for Hypercapnic Respiratory Failure: AVAPS vs S/T BIPAP

👨‍⚕️ Margarita Oks, MD, Lenox Hill Hospital/Northwell Health📍 1 site📅 Started Oct 2023View details ↗
Phase 2RecruitingNCT06940791

Tirabrutinib Maintenance Versus Placebo in Patients With Primary CNS Lymphoma in Complete Remission (JCOG2104)

🏥 Kyorin University📍 1 site📅 Started Oct 2023View details ↗
Enrolling by InvitationNCT05557721

Uddevalla Skövde Transscleral Micropulse Study

👨‍⚕️ Tobias Dahlgren, MD, Vastra Gotaland Region📍 2 sites📅 Started Oct 2023View details ↗
RecruitingNCT06357754

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

👨‍⚕️ Bristol-Myers Squibb, Bristol-Myers Squibb📍 8 sites📅 Started Oct 2023View details ↗
NARecruitingNCT06132750

A 5-year Natural History Study in LAMA2-related Muscular Dystrophy and SELENON-related Myopathy.

👨‍⚕️ Ilse de Laat📍 1 site📅 Started Oct 2023View details ↗
NARecruitingNCT05774002

Psychological Assessment of Scoliosis Patients Undergoing Surgical Management

👨‍⚕️ Eric D Fornari, MD, Montefiore Medical Center📍 1 site📅 Started Oct 2023View details ↗
NARecruitingNCT06103669

Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS)

👨‍⚕️ Xiao Zhao, MD, University of California, Davis📍 1 site📅 Started Oct 2023View details ↗
NARecruitingNCT06101277

Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)

👨‍⚕️ Edward Kim, MD, PhD, University of California, Davis📍 1 site📅 Started Oct 2023View details ↗
NARecruitingNCT06158646

Mechanically or Kinematically Aligned Total Knee Prosthesis

🏥 Clinique du Sport, Bordeaux Mérignac📍 1 site📅 Started Oct 2023View details ↗
NARecruitingNCT06101290

Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)

👨‍⚕️ Mamta Parikh, MD, MS, University of California, Davis📍 1 site📅 Started Oct 2023View details ↗
Phase 2RecruitingNCT06061146

Tislelizumab Plus Concurrent Chemoradiation in Older With ESCC

👨‍⚕️ Wencheng Zhang, M.D, Tian jin cancer hospital📍 1 site📅 Started Oct 2023View details ↗
Phase 1RecruitingNCT05934838

A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas

👨‍⚕️ Samuel Yamshon, M.D., Weill Medical College of Cornell University📍 1 site📅 Started Oct 2023View details ↗
Phase 1, PHASE2RecruitingNCT06040320

Polatuzumab Vedotin (Pola) Plus Rituximab (R) in Patients With Post-transplant Lymphoproliferative Disorder (PTLD)

👨‍⚕️ Neha Mehta-Shah, M.D., Washington University School of Medicine📍 1 site📅 Started Oct 2023View details ↗
Enrolling by InvitationNCT06109935

Special Use-results Surveillance on Long Term Use of Sogroya® in Children With Short Stature Due to Growth Hormone Deficiency Where Epiphysial Discs Are Not Closed

👨‍⚕️ Clinical Transparency dept. 2834, Novo Nordisk A/S📍 86 sites📅 Started Oct 2023View details ↗
RecruitingNCT06594302

Functional Performance and Biopsychosocial Characteristics in Individuals with Systemic Sclerosis

🏥 Hacettepe University📍 1 site📅 Started Oct 2023View details ↗
RecruitingNCT06324539

Validation of a New Innovative Method for Specific Marker Detection in Celiac Disease

🏥 IRCCS Burlo Garofolo📍 4 sites📅 Started Oct 2023View details ↗
Phase 3Enrolling by InvitationNCT06044337

A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

👨‍⚕️ Medical Director, Biogen📍 94 sites📅 Started Oct 2023View details ↗
← PreviousPage 371 of 624Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →